Variables | All (n = 88) | Non-survivors (n = 47) | Survivors (n = 41) | p value |
---|---|---|---|---|
Bacteremia, n (%) | 52 (59.1) | 27 (57.4) | 25 (61.0) | 0.83 |
Infection Source, n (%) | ||||
 Respiratory tract infection | 16 (18.2) | 13 (27.7) | 3 (7.3) | 0.03* |
 Urinary tract infection | 13 (14.8) | 5 (10.6) | 8 (19.5) | 0.37 |
 Spontaneous bacterial peritonitis | 30 (34.1) | 19 (40.4) | 11 (26.8) | 0.26 |
 Biliary tract infection | 9 (10.2) | 1 (2.1) | 8 (19.5) | 0.01* |
 Soft tissue infection | 12 (13.6) | 4 (8.5) | 8 (19.5) | 0.21 |
 Other | 8 (9.1) | 5 (10.6) | 3 (7.3) | 0.72 |
Appropriate antibiotics, n (%) | 65 (73.9) | 35 (74.5) | 30 (73.2) | 1.00 |
Source control, n (%) | 11 (12.5) | 2 (4.3) | 9 (22.0) | 0.02* |
1st dose antibiotics administration time, minutes, median (IQR) | 85.0 (44.8–149.5) | 94.0 (47.0–150) | 70.0 (29.5–165) | 0.31 |
Vasopressor initiation time, minutes, median (IQR) | 103.0 (68–151.3) | 115.0 (70–175) | 80.0 (51–133.5) | 0.37 |
Fluid amount, L, median (IQR) | 1.2 (0.7–1.6) | 1.0 (0.5–1.5) | 1.3 (1.0–1.6) | 0.16 |
Hour-1 bundle achievement, n (%) | 27 (30.7) | 12 (25.5) | 15 (36.6) | 0.35 |